Cargando…
Pattern of urinary albumin excretion in normotensive young and adolescent Indian women with polycystic ovary syndrome
OBJECTIVE: Polycystic ovarian syndrome (PCOS) is a clinically heterogeneous endocrine disorder affecting up to 4–8% of women of reproductive age. The aim of this study was to evaluate the presence of microalbuminuria in women with PCOS and study its correlation with the various metabolic, clinical,...
Autores principales: | Ganie, Mohd Ashraf, Farooqui, Khalid Jamal, Bhat, Mohd Ashraf, Mir, Mohammad Muzzafar, Shah, Zaffar Amin, Douhath, Syed, Mir, Syed Hussain, Rashid, Fouzia, Naqshi, Shazia, Masoodi, Mohd Ibrahim, Zargar, S. A., Zargar, Abdul Hamid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313749/ https://www.ncbi.nlm.nih.gov/pubmed/22470868 http://dx.doi.org/10.4103/2230-8210.93752 |
Ejemplares similares
-
Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India
por: Shabir, Iram, et al.
Publicado: (2014) -
Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: An observational pilot study
por: Yousuf, Syed Douhath, et al.
Publicado: (2018) -
The Lys469glu/K469E Polymorphism of the Inflammatory Gene Intercellular Adhesion Molecule-1 Lacks any Apparent Role in the Polycystic Ovary Syndrome in Kashmiri Women: A Case Control Study
por: Yousuf, Syed Douhath, et al.
Publicado: (2017) -
Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study
por: Yousuf, Syed Douhath, et al.
Publicado: (2022) -
Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
por: Yousuf, Syed Douhath, et al.
Publicado: (2023)